Dengue Fever
📧 Sign up to get email alerts when something new happens for Dengue Fever.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: A Study to Evaluate V181 Dengue Vaccine in Healthy Participants 2 to 17 Years of Age (V181-005/MOBILIZE-1) [Phase 3]
A Phase 3 clinical trial to evaluate the V181 dengue vaccine in healthy participants aged 2 to 17, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Investigating Vector-Borne Determinants of Aedes Transmitted Arboviral Infections in Cambodia: An Observational Longitudinal Cohort Study in Children
A completed observational longitudinal cohort study in Cambodian children examining determinants of Aedes-transmitted arboviral infections, …
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years) [Phase 3]
A Phase 3 clinical trial evaluating the Dengue Tetravalent Vaccine (TDV) in adults aged 45-60 and 60-79, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study in Children and Teenagers to Learn if a TDV Dengue Vaccination Lowers the Chance of Hospital Stays for Dengue
A pediatric and adolescent clinical trial is evaluating whether the TDV Dengue Vaccine reduces hospital stays for dengue and the study is cu…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Xpert® Tropical Fever Test on GeneXpert® Edge X System
A clinical trial update indicates Cepheid is enrolling by invitation to evaluate the Xpert Tropical Fever Test on the GeneXpert Edge X Syste…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of AV-1 Against Dengue Virus 3 (DENV-3) Infection [Phase 2]
A Phase 2 study evaluating the safety and efficacy of AV-1 against Dengue virus serotype 3 infection has completed in a controlled human inf…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Testing Combined IIT-SIT to Control Mosquito-Borne Diseases At Scale [NA]
This clinical trial update reports termination of a study evaluating combined IIT-SIT technology to control dengue fever, Zika virus disease…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Evaluation of the Protective Efficacy of TV003 or Previous Zika Infection Against Infection With ZIKV-SJRP Challenge Compared to DENV and ZIKV-naïve Controls Against Infection With ZIKV-SJRP Challenge [Phase 1]
Phase 1 clinical trial assessing whether TV003 vaccination or prior Zika exposure provides protection against ZIKV-SJRP challenge compared w…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Trial to Evaluate the Immunogenicity and Safety of the Co-administration of Live Attenuated Dengue and Chikungunya Vaccines Compared to Separate Administration in Adults Aged 18 to 59 Years. [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of co-administered live attenuated dengue and chikungunya vaccines versus separate admini…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Prediction of Infectious Diseases in LMICs Using Electronic Health Record Data
A completed clinical trial from Mahidol University evaluated using electronic health record data to predict infectious diseases in LMICs, fo…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: International Registry of Dengue Infection in Congenital Bleeding Disorders (DengueCBDR)
Clinical trial registry entry for the DengueCBDR study, a recruiting international registry investigating dengue infection in people with co…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy Adults [Phase 3]
Takeda's tetravalent dengue vaccine (TDV) is in a Phase 3 trial in healthy adults, with the study currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Characterizing Humoral Immune Response to Mosquito Bites [NA]
A completed University of Oxford clinical trial studied the humoral immune response to mosquito bites in the contexts of malaria and dengue …
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
An ongoing recruitment update for a One Health study evaluating the risk of community spread of multiple endemic infectious diseases. The st…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: The Effectiveness of the Board Game on Primary Healthcare Nurses' Knowledge, Attitudes, and Confidence in Dengue-related Practice [NA]
This ClinicalTrials.gov update reports a completed study by Taipei Medical University evaluating a board game to improve primary healthcare …
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: A Study of Dengue Tetravalent Vaccine (TDV) in Healthy Participants in Japan [Phase 2, Phase 3]
Takeda completed Phase 2 and Phase 3 trials of the Dengue Tetravalent Vaccine (TDV) in healthy participants in Japan.
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: Emetine for Viral Outbreaks (a.k.a. EVOLVE Antiviral Initiative) [Phase 2, Phase 3]
The document reports a Phase 2/Phase 3 clinical trial evaluating emetine for dengue under the EVOLVE Antiviral Initiative. The study status …
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: A Study of Dengue Vaccine in Healthy Children, Teenagers and Adults in India [Phase 3]
Takeda's dengue vaccine TAK-003 was studied in a Phase 3 trial in healthy children, teenagers and adults in India, and the study has complet…
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: A Cluster-randomized Trial to EValuate the Efficacy of Wolbachia-InfecTed Aedes Aegypti Mosquitoes in Reducing the Incidence of Arboviral Infection in Brazil (EVITA Dengue) [NA]
This update reports the completion of a cluster-randomized trial in Brazil assessing whether releasing Wolbachia-infected Aedes aegypti mosq…
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: Trial to Model Primary, Secondary, and Tertiary Dengue Using a Monovalent Vaccine [Phase 1]
A Phase 1 clinical trial of a monovalent dengue vaccine to model primary, secondary, and tertiary dengue exposure is currently active but no…
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: Evaluating Public Awareness and Preventive Actions for Dengue Fever in Sudan Amidst Ongoing Crises
This trial update reports a completed study evaluating public awareness and preventive actions for dengue fever in Sudan amid ongoing crises…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus Infection
This clinical trial update describes a study investigating risk factors for hospitalization and transfusion thresholds in patients with deng…
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: To Assess the Efficacy of Carica Papaya Leaf Extract in Improving Platelet Counts Among Pediatric Patients With Dengue-associated Thrombocytopenia [Phase 2]
Phase 2 clinical trial update evaluating Carica Papaya Leaf Extract for improving platelet counts in pediatric dengue-associated thrombocyto…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: Clinical Trial Evaluating Safety and Efficacy of Resomelagon on Dengue Infection (RESOVIR-2) [Phase 2]
This document reports a Phase 2 clinical trial evaluating the safety and efficacy of Resomelagon for dengue fever (RESOVIR-2), currently not…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: The Interest of Systematic Screening for Dengue, Chikungunya, and Zika, in Malaria-negative Return Travelers
Clinical trial update assessing systematic screening for dengue, chikungunya, and Zika among malaria-negative travelers returning from endem…